Engineered Riboswitch Nano-carriers as a Possible Disease-Modifying Treatment for Metabolic Disorders
S. Zilberzwige-Tal, D. Gazit, H. Adsi, M. Gartner, R. Behl, D. Laor, E. Gazit
This paper engineers RNA-virus-like nanocarriers with riboswitches to treat metabolic disorders by inhibiting metabolite self-assembly and reducing amyloid-like structures in yeast.
bioRxiv · May 16, 2022 · PreprintBioengineering